Current filters:


1 to 9 of 12 results

Actavis prevails in Lialda patent dispute in USA

Actavis prevails in Lialda patent dispute in USA


US generics major Actavis says that the US Court of Appeals for the Federal Circuit has reversed a lower…

ActavisGastro-intestinalsGenericsLegalLialdaNorth AmericaPatentsShireUSA

Shire prevails in US Lialda patent dispute with Watson


Ireland-headquartered drugmaker Shire's (LSE: SHP) subsidiary Shire Development has prevailed in its…

ActavisGastro-intestinalsGenericsLegalLialdaNorth AmericaPatentsPharmaceuticalShireWatson Pharmaceuticals

Shire takes hit as bowel disease drug Lialda fails in Ph III trial


The shares of Ireland-headquartered Shire (LSE: SHP) dropped 4.9% to £20.14 in mid afternoon trading…


Shire gets US Rights to Resolor


Ireland-headquartered specialty biopharma firm Shire (LSE: SHP) says that it has acquired the rights…

Gastro-intestinalsMarkets & MarketingMergers & AcquisitionsNorth AmericaPharmaceuticalResolorShire

Shire’s Lialda now OKed for ulcerative colitis maintenance of remission in the USA


The US Food and Drug Administration has approved Ireland-headquartered specialty drugmaker Shire’s…

Gastro-intestinalsLialdaNorth AmericaPharmaceuticalRegulationShire

Highlights from Digestive Disease Week


The 2011 Digestive Disease Week meeting in Chicago, USA, heard a number of interesting presentations…

Abbott LaboratoriesDificidGastro-intestinalsJohnson & JohnsonLubiprostoneOptimer PharmaceuticalsPharmaceuticalRemicadeResearchResolorShireStelara InjectionSucampo

Shire says 2nd-qtr 2010 revenues rose 35% and EPS leapt 71%; updates on Firazyr; Movetis’ Resolor cleared in Switzerland


UK specialty drugmaker Shire, which has moved its headquarters to Ireland for tax reasons, posted rocketing…

BiotechnologyFinancialFirazyrGastro-intestinalsMovetisPharmaceuticalRare diseasesRegulationResearchResolorShire

Shire buying Movetis for $558 million to expand specialist gastrointestinal portfolio


Dublin, Ireland-based specialty biopharmaceutical company Shire revealed yesterday that it will launch…

Gastro-intestinalsGeneralMergers & AcquisitionsMovetisPharmaceuticalResolorShire

1 to 9 of 12 results

Back to top